Amlodipine Besylate
Product Images NDC 42582-313

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 42582-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bi-coastal Pharma International Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Container Label 10 mg)

This is a medication with NDC number 42582-315-09 containing 10 mg Amlodipine besylate USP per tablet. It is recommended to store the tablets between 20 and 25 degrees Celsius, protecting them from light. The medication should be dispensed in light-resistant containers and includes a patient information leaflet. The manufacturer is Vivimed Labs (Alathur) Private Limited for Bi-Coastal Pharma International LLC in the USA. This text provides general medication information and instructions.*

FDA Label Image

Image Description (Container Label 2 5 mg)

This is a medication with the NDC code 42582-313-09 containing amlodipine besylate USP equivalent to 2.5 mg amlodipine per tablet. The dosage and use information can be found in the accompanying prescribing information. It should be stored at a temperature of 20° to 25° C (68° to 77° F) and protected from light in tight, light-resistant containers as defined in the USP. It was manufactured by Vivimed Labs (Alathur) Private Limited and packaged for Bi-Coastal Pharma International LLC. This information is listed on a patient information leaflet with a M.L. number of TN00002326. The lot number is available but not included in the text.*

FDA Label Image

Image Description (Container Label 5 mg)

This is a description of Amlodipine Besylate Tablets, a medication used for hypertension and angina. Each tablet contains 5mg of Amlodipine Besylate USP. Dosage and prescribing information can be found in the accompanying Patient Information Leaflet. The medication should be stored at 20°C to 25°C and protected from light. It should be dispensed in tight, light-resistant containers. This specific batch was manufactured by Vivimed Labs (Alathur) Private Limited in India, and is being distributed by Bi-Coastal Pharma International LLC in the USA. The NDC for this medication is 42582-314-09. The lot number and expiration date are not available.*

FDA Label Image

Figure 1

This appears to be a statistical analysis output showing event rate with P-value, hazard ratio, and confidence interval for a certain time period. It also includes a graph with a line for Amlodipine and a risk value at the 24-month mark.*

FDA Label Image

Figure 2

This is a table of results from a study comparing the effects of a drug (Amlodipine) to a placebo. The table contains information on different patient groups based on age, gender, baseline sitting SBP, baseline vessel diseases, and PCI-stent strata. However, without additional information on the purpose and methodology of the study, it is not possible to provide a more specific description or analysis.*

FDA Label Image

Image 1

FDA Label Image

Image 2

FDA Label Image

Image 3

FDA Label Image

Image 4

FDA Label Image

Image 5

FDA Label Image

Image 6

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.